JP2019536783A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536783A5
JP2019536783A5 JP2019528632A JP2019528632A JP2019536783A5 JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5 JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019528632 A JP2019528632 A JP 2019528632A JP 2019536783 A5 JP2019536783 A5 JP 2019536783A5
Authority
JP
Japan
Prior art keywords
tyrosine
methyl
cancer
composition according
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019528632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019536783A (ja
Filing date
Publication date
Priority claimed from US15/365,120 external-priority patent/US20170080093A1/en
Application filed filed Critical
Priority claimed from PCT/US2017/063865 external-priority patent/WO2018102506A1/en
Publication of JP2019536783A publication Critical patent/JP2019536783A/ja
Publication of JP2019536783A5 publication Critical patent/JP2019536783A5/ja
Priority to JP2022122538A priority Critical patent/JP2022153587A/ja
Pending legal-status Critical Current

Links

JP2019528632A 2016-11-30 2017-11-30 チロシン誘導体及びそれらを含む組成物 Pending JP2019536783A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022122538A JP2022153587A (ja) 2016-11-30 2022-08-01 チロシン誘導体及びそれらを含む組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/365,120 US20170080093A1 (en) 2013-10-22 2016-11-30 Tyrosine Derivatives And Compositions Comprising Them
US15/365,120 2016-11-30
PCT/US2017/063865 WO2018102506A1 (en) 2016-11-30 2017-11-30 Tyrosine derivatives and compositions comprising them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022122538A Division JP2022153587A (ja) 2016-11-30 2022-08-01 チロシン誘導体及びそれらを含む組成物

Publications (2)

Publication Number Publication Date
JP2019536783A JP2019536783A (ja) 2019-12-19
JP2019536783A5 true JP2019536783A5 (https=) 2021-01-14

Family

ID=60703174

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019528632A Pending JP2019536783A (ja) 2016-11-30 2017-11-30 チロシン誘導体及びそれらを含む組成物
JP2022122538A Withdrawn JP2022153587A (ja) 2016-11-30 2022-08-01 チロシン誘導体及びそれらを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022122538A Withdrawn JP2022153587A (ja) 2016-11-30 2022-08-01 チロシン誘導体及びそれらを含む組成物

Country Status (12)

Country Link
EP (1) EP3548086A1 (https=)
JP (2) JP2019536783A (https=)
KR (1) KR20190089191A (https=)
CN (1) CN110062633A (https=)
AU (1) AU2017368135A1 (https=)
BR (1) BR112019011033A2 (https=)
CA (1) CA3045110A1 (https=)
EA (1) EA201991305A1 (https=)
IL (1) IL266840A (https=)
MX (1) MX2019006326A (https=)
PH (1) PH12019501186A1 (https=)
WO (1) WO2018102506A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111743887A (zh) * 2019-03-26 2020-10-09 深圳先进技术研究院 α-甲基酪氨酸或其衍生物的用途
WO2020232227A1 (en) 2019-05-14 2020-11-19 Tyme, Inc. Compositions and methods for treating cancer
CN115379851A (zh) * 2019-11-07 2022-11-22 因斯瑞拜奥有限公司 使用生长因子抗体与非酪氨酸靶向激酶抑制剂的组合的方法和组合物
IL294803A (en) * 2020-01-17 2022-09-01 Tyme Inc Tyrosine derivatives for modulating cancer
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2005072061A2 (en) * 2004-02-02 2005-08-11 Biosight Ltd. Conjugates for cancer therapy and diagnosis
BRPI0621580B8 (pt) * 2006-04-19 2021-05-25 Univ Texas composto derivado de n4 e kit compreendendo o referido composto e um agente redutor
HRP20160625T1 (hr) * 2007-09-10 2016-08-12 Boston Biomedical, Inc. Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
PH12014501639B1 (en) * 2012-01-17 2023-02-22 Tyme Inc Pharmaceutical compositions and methods
US9585841B2 (en) * 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them

Similar Documents

Publication Publication Date Title
JP2019536783A5 (https=)
JPWO2020130125A1 (ja) 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ
JP2019504100A5 (https=)
JP2018533582A5 (https=)
JP2022510962A5 (https=)
JP2012505838A5 (https=)
JP2006265245A5 (https=)
JP2022551652A (ja) 線維芽細胞増殖因子受容体シグナル伝達の調節不全を伴う癌の標的処置
RU2016127634A (ru) Гетероциклические модуляторы синтеза липидов для применения против рака и вирусных инфекций
WO2010086964A1 (ja) がん治療のための併用療法
CN110478487A (zh) 一种大环内酯化合物在逆转肿瘤多药耐药增强抗肿瘤疗效方面的应用
JP2022153587A (ja) チロシン誘導体及びそれらを含む組成物
US20220387544A1 (en) Novel therapeutic use
KR102929813B1 (ko) 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용
CN101715342A (zh) 钴胺素紫杉烷生物结合物
JP2023517671A5 (https=)
EP4204428A1 (en) 5'-substituted nucleoside monophosphates, prodrugs thereof, and uses related thereto
US11110105B2 (en) Compounds, composition and uses thereof for treating cancer
AU2013233094A1 (en) Novel antitumor agent comprising combination of three agents
JP2020535112A (ja) Ｍｉｄｈ１阻害剤とｄｎａ低メチル化剤（ｈｍａ）との組合せ
CN103826645A (zh) 砷在癌症治疗保护中的用途
CA3059270C (en) Compounds, composition and uses thereof fortreating cancer
JP2025128194A (ja) 哺乳動物の身体におけるｍｙｃ発現腫瘍のタウロリジン治療
JP2022543021A5 (https=)
US20130018028A1 (en) Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate)